[Pre-exposure rabies vaccination].
Prophylactic vaccinations against rabies were given to 150 occupationally exposed persons. A new killed vaccine, grown on human diploid cells, was used. The first immunization resulted in a rapid development of neutralizing antibodies. Antibodies declined very quickly so that 50% of the probands failed to show adequate titres after 12 months. All probands reacted with a distinct rise in antibodies on re-vaccination. The vaccine was well tolerated and local or general reactions were observed only rarely.
D004334:Drug Administration Schedule; D006801:Humans; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000627:therapeutic use*
D011819:Rabies Vaccines
Die präexpositionelle Schutzimpfung gegen Tollwut.